Literature DB >> 1119492

Angiogenesis of cervical neoplasia.

A Stafl, R F Mattingly.   

Abstract

Recent studies concerning the role of an angiogenic factor in cancer have produced a renewed interest in vascular studies of the cervix. Colposcopic and histochemical vascular studies demonstrate changes in the vascular pattern of cervical neoplasia which progress from early dysplasia to carcinoma in situ. There is a restructuring of the terminal vascular network of the pre-existing columnar epithelium in noninvasive cervical neoplasia which is caused by compression of the capillaries by the epithelial proliferation. In contrast, neovascularization is observed in those cases of carcinoma in situ which will progress to invasive cancer. The position is taken that this process of neovascularization, which is recognized by the development of horizontal vessels, may be the direct effect of an angiogenic factor. Evidence is also presented that the initial vascular changes may precede the histopathologic criteria of cervical neoplasia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1119492

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  [Colposcopy--retrospect and prospects].

Authors:  E Burghardt
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

2.  Diagnostic Value of Circulating PIGF in Combination with Flt-1 in Early Cervical Cancer.

Authors:  Shou-Hua Yang; Xiao-Ling Wang; Jing Cai; Shao-Hai Wang
Journal:  Curr Med Sci       Date:  2020-10-29

3.  Human papillomavirus oncoproteins induce a reorganization of epithelial-associated γδ T cells promoting tumor formation.

Authors:  Dorien Van Hede; Barbara Polese; Chantal Humblet; Anneke Wilharm; Virginie Renoux; Estelle Dortu; Laurence de Leval; Philippe Delvenne; Christophe J Desmet; Fabrice Bureau; David Vermijlen; Nathalie Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-10       Impact factor: 11.205

4.  Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia.

Authors:  S P Dobbs; P W Hewett; I R Johnson; J Carmichael; J C Murray
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  New molecular targets against cervical cancer.

Authors:  Alfonso Duenas-Gonzalez; Alberto Serrano-Olvera; Lucely Cetina; Jaime Coronel
Journal:  Int J Womens Health       Date:  2014-12-05

6.  Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.

Authors:  Shouhua Yang; Henghui Cheng; Zaiju Huang; Xiaoling Wang; Yinglu Wan; Jing Cai; Zehua Wang
Journal:  Dis Markers       Date:  2015-03-19       Impact factor: 3.434

Review 7.  Angiogenesis and antiangiogenic agents in cervical cancer.

Authors:  Federica Tomao; Anselmo Papa; Luigi Rossi; Eleonora Zaccarelli; Davide Caruso; Federica Zoratto; Pierluigi Benedetti Panici; Silverio Tomao
Journal:  Onco Targets Ther       Date:  2014-12-03       Impact factor: 4.147

8.  A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix.

Authors:  Chao Chen; Shukui Qin; Zixiong Li; Xianwen Luo; Yu Zhang; Jue Zhang; Xiufeng Liu
Journal:  Onco Targets Ther       Date:  2019-07-17       Impact factor: 4.147

9.  Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial.

Authors:  Jun Zhu; Chunyan Song; Zhong Zheng; Lingfang Xia; Yanqiong Chen; Guihao Ke; Xiaohua Wu
Journal:  Front Oncol       Date:  2021-11-02       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.